Inhibition of Junín virus replication by small interfering RNAs

Junín virus (JUNV), the etiological agent of the Argentine hemorrhagic fever, has a single-stranded RNA genome with ambisense expression which encodes for five proteins. In previous works we have demonstrated that the Z arenavirus matrix protein represents an attractive target for antiviral therapy....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Artuso, M.C
Otros Autores: Ellenberg, P.C, Scolaro, L.A, Damonte, E.B, García, C.C
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2009
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13643caa a22014057a 4500
001 PAPER-23076
003 AR-BaUEN
005 20230518205443.0
008 190411s2009 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-69249213996 
024 7 |2 Molecular Sequence Numbers  |a GENBANK: AF004519, AY619640, AY819707, DQ538136, NC_004292, NC_005080; 
024 7 |2 cas  |a RNA, Small Interfering 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a ARSRD 
100 1 |a Artuso, M.C. 
245 1 0 |a Inhibition of Junín virus replication by small interfering RNAs 
260 |c 2009 
270 1 0 |m García, C.C.; Laboratory of Virology, Department of Biological Chemistry, School of Sciences, Ciudad Universitaria, Pabellon 2, Piso 4, 1428 Buenos Aires, Argentina; email: cygarcia@qb.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Bernstein, E., Caudy, A.A., Hammond, S.M., Hannon, G.J., Role for a bidentate ribonuclease in the initiation step of RNA interference (2001) Nature, 409, pp. 363-366 
504 |a Borden, K.L., Campbell-Dwyer, E.J., Salvato, M.S., An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm (1998) J. Virol., 72, pp. 758-766 
504 |a Campbell-Dwyer, E.J., Lai, H., MacDonald, R.C., Salvato, M.S., Borden, K.L., The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner (2000) J. Virol., 74, pp. 3293-3300 
504 |a Candurra, N.A., Damonte, E.B., Coto, C.E., Antigenic relationships between attenuated and pathogenic strains of Junin virus (1989) J. Med. Virol., 27, pp. 145-150 
504 |a Chung, Y.-S., Kim, M.-K., Lee, W.-J., Kang, C., Silencing E1A mRNA by RNA interference inhibits adenovirus replication (2007) Arch. Virol., 152, pp. 1305-1314 
504 |a Cornu, T.I., de la Torre, J.C., Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis (2002) J. Virol., 76, pp. 6678-6688 
504 |a Cornu, T.I., de la Torre, J.C., RING finger Z protein of Lymphocytic Choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome (2001) J. Virol., 75, pp. 9415-9426 
504 |a Damonte, E.B., Coto, C.E., Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy (2002) Adv. Virus Res., 58, pp. 125-155 
504 |a Davis, M.E., The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic (2009) Mol. Pharm., 6, pp. 659-668 
504 |a Djavani, M., Topisirovic, I., Zapata, J.C., Sadowska, M., Yang, Y., Rodas, J., Lukashevich, I.S., Salvato, M.S., The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus (2005) J. Virol., 79, pp. 2461-2473 
504 |a Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W., Tuschl, T., Functional anatomy of siRNA for mediating efficient RNAi in Drosophila melanogaster embryo lysate (2001) EMBO J., 20, pp. 6877-6888 
504 |a Fowler, T., Bamberg, S., Möller, P., Klenk, H.D., Meyer, T.F., Becker, S., Rudel, T., Inhibition of Marburg virus protein expression and viral release by RNA interference (2005) J. Gen. Virol., 86, pp. 1181-1188 
504 |a García, C.C., Candurra, N.A., Damonte, E.B., Differential inhibitory action of two azoic compounds against arenaviruses (2003) Int. J. Antimicrob. Agents, 21, pp. 319-324 
504 |a García, C.C., Djavani, M., Topisirovic, I., Borden, K.L., Salvato, M.S., Damonte, E.B., Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds (2006) J. Gen. Virol., 87, pp. 1217-1228 
504 |a Gitlin, L., Stone, J.K., Andino, R., Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches (2005) J. Virol., 79, pp. 1027-1035 
504 |a Hammond, S.M., Bernstein, E., Beach, D., Hannon, G.J., An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells (2000) Nature, 404, pp. 293-296 
504 |a Hannon, G.J., Rossi, J.J., Unlocking the potential of the human genome with RNA interference (2004) Nature, 431, pp. 371-378 
504 |a Hutvágner, G., McLachlan, J., Pasquinelli, A.E., Bálint, E., Tuschl, T., Zamore, P.D., A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA (2001) Science, 293, pp. 834-838 
504 |a Jiang, M., Milner, J., Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference (2002) Oncogene, 21, pp. 6041-6048 
504 |a Leung, R.K.M., Whittaker, P.A., RNA interference: from gene silencing to gene-specific therapeutics (2005) Pharmacol. Ther., 107, pp. 222-239 
504 |a Li, G.Q., Xu, W.Z., Wang, J.X., Deng, W.W., Li, D., Gu, H.X., Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells (2007) World J. Gastroenterol., 13, pp. 2324-2327 
504 |a Liu, M., Ding, H., Zhao, P., Qin, Z.L., Gao, J., Cao, M.M., Luan, J., Qi, Z.T., RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells (2006) Biosci. Biotechnol. Biochem., 70, pp. 2049-2055 
504 |a López, N., Jácomo, R., Franze-Fernández, M.T., Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor oh these processes (2001) J. Virol., 75, pp. 12241-12251 
504 |a López-Fraga, M., Wright, N., Jiménez, A., RNA interference-based therapeutics: new strategies to fight infectious disease (2008) Infect. Disord. Drug Targets, 8, pp. 262-273 
504 |a Lupberger, J., Brino, L., Baumer, T.F., RNAi-a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle (2008) J. Hepatol., 48, pp. 523-525 
504 |a Ma, Y., Chan, C.Y., He, M.L., RNA interference and antiviral therapy (2007) World J. Gastroenterol., 13, pp. 5169-5179 
504 |a Müller, S., Günther, S., Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus (2007) Antimicrob. Agents Chemother., 51, pp. 2215-2218 
504 |a Naito, Y., Nohtomi, K., Onogi, T., Uenishi, R., Ui-Tei, K., Saigo, K., Takebe, Y., Optimal design and validation of antiviral siRNA for targeting HIV-1 (2007) Retrovirology, 4, p. 80 
504 |a Neuman, B.W., Adair, B.D., Burns, J.W., Milligan, R.A., Buchmeier, M.J., Yeager, M., Complementary in the supramolecular design of arenavirus and retroviruses revealed by electron cryomicroscopy and image analysis (2005) J. Virol., 79, pp. 3822-3830 
504 |a Perez, M., Craven, R.C., de la Torre, J.C., The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies (2003) Proc. Natl. Acad. Sci. U.S.A., 100, pp. 12978-12983 
504 |a Perez, M., Greenwald, D.L., de la Torre, J.C., Myristoylation of the RING finger Z protein is essential for arenavirus budding (2004) J. Virol., 78, pp. 11443-11448 
504 |a Salvato, M.S., Molecular biology of the prototype arenavirus, lymphocytic choriomeningitis virus (1993) The Arenaviridae, pp. 133-156. , Salvato M.S. (Ed), Plenum Press, New York 
504 |a Salvato, M.S., Schweighofer, K.J., Burns, J., Shimomaye, E.M., Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus (1992) Virus Res., 22, pp. 185-198 
504 |a Sánchez, A.B., Perez, M., Cornu, T., de la Torre, J.C., RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus (2005) J. Virol., 79, pp. 11071-11081 
504 |a Sánchez, A., Pifat, D.Y., Kenyon, R.H., Peters, C.J., McCormick, J.B., Kiley, M.P., Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses (1989) J. Gen. Virol., 70, pp. 1125-1132 
504 |a Strecker, T., Eichler, R., ter Meulen, J., Weissenhorn, W., Klenk, H.D., Garten, W., Lenz, O., Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles (2003) J. Virol., 77, pp. 10700-10705 
504 |a Zamore, P.D., Tuschl, T., Sharp, P.A., Bartel, D.P., RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals (2000) Cell, 101, pp. 25-33 
504 |a Zhang, Y., Li, T., Fu, L., Yu, C., Li, Y., Xu, X., Wang, Y., Chang, Z., Silencing SARS-CoV spike protein expression in cultured cells by RNA interference (2004) FEBS Lett., 27, pp. 141-146 
520 3 |a Junín virus (JUNV), the etiological agent of the Argentine hemorrhagic fever, has a single-stranded RNA genome with ambisense expression which encodes for five proteins. In previous works we have demonstrated that the Z arenavirus matrix protein represents an attractive target for antiviral therapy. With the aim of studying a new alternative therapeutic mechanism, four Z-specific siRNAs (Z1- to Z4-siRNAs) were tested showing variable efficacy. The most effective inhibitor was Z2-siRNA targeted at the region encompassed by nt 179-197 of Z gene. The efficacy of this Z2-siRNA against JUNV was also demonstrated in virus-infected cells, by testing infectious virus plaque formation (92.8% JUNV yield reduction), viral RNA level or antigen expression, as well as in cells transfected with Z-specific reporter plasmids (91% reduction in expression of Z-EGFP fusion protein). Furthermore, the lack of effect of this Z-siRNA on the expression of other JUNV proteins, such as N and GPC, confirmed the specificity of action exerted by Z2-siRNA on Z transcript. Thus, the present study represents the first report of virus inhibition mediated by RNA interference for a New World arenavirus. © 2009 Elsevier B.V. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Agencia Nacional de Promoción Científica y Tecnológica 
536 |a Detalles de la financiación: Universidad de Buenos Aires 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: Fundación Bunge y Born 
536 |a Detalles de la financiación: This work was supported by funding to the group from the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Agencia Nacional de Promoción Científica y Tecnológica, Universidad de Buenos Aires, and Fundación Bunge and Born, Argentina. CCG, LAS and EBD are members of the Research Career from CONICET. We are thankful to Dr A. Sanchez and Dr T. Ksiazek (CDC, Atlanta, GA) for providing JUNV mAbs. 
593 |a Laboratory of Virology, Department of Biological Chemistry, School of Sciences, Ciudad Universitaria, Pabellon 2, Piso 4, 1428 Buenos Aires, Argentina 
690 1 0 |a ARENAVIRUS 
690 1 0 |a JUNIN VIRUS 
690 1 0 |a MATRIX PROTEIN 
690 1 0 |a RNA INTERFERENCE 
690 1 0 |a SIRNAS 
690 1 0 |a GUANINE NUCLEOTIDE BINDING PROTEIN 
690 1 0 |a SMALL INTERFERING RNA 
690 1 0 |a VIRUS ANTIGEN 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ANTIGEN EXPRESSION 
690 1 0 |a ARTICLE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DRUG EFFICACY 
690 1 0 |a DRUG SPECIFICITY 
690 1 0 |a DRUG TARGETING 
690 1 0 |a GENETIC TRANSFECTION 
690 1 0 |a HUMAN 
690 1 0 |a HUMAN CELL 
690 1 0 |a JUNIN VIRUS 
690 1 0 |a NONHUMAN 
690 1 0 |a NUCLEOTIDE SEQUENCE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN EXPRESSION 
690 1 0 |a RNA INTERFERENCE 
690 1 0 |a VIRUS INHIBITION 
690 1 0 |a VIRUS PLAQUE 
690 1 0 |a VIRUS REPLICATION 
690 1 0 |a ANIMALS 
690 1 0 |a ARENAVIRIDAE INFECTIONS 
690 1 0 |a BASE SEQUENCE 
690 1 0 |a CELL LINE 
690 1 0 |a CERCOPITHECUS AETHIOPS 
690 1 0 |a CRICETINAE 
690 1 0 |a DOWN-REGULATION 
690 1 0 |a JUNIN VIRUS 
690 1 0 |a MOLECULAR SEQUENCE DATA 
690 1 0 |a RNA INTERFERENCE 
690 1 0 |a RNA, SMALL INTERFERING 
690 1 0 |a SEQUENCE ALIGNMENT 
690 1 0 |a VERO CELLS 
690 1 0 |a VIRUS REPLICATION 
690 1 0 |a ARENAVIRUS 
690 1 0 |a JUNIN VIRUS 
650 1 7 |2 spines  |a VIRUS RNA 
700 1 |a Ellenberg, P.C. 
700 1 |a Scolaro, L.A. 
700 1 |a Damonte, E.B. 
700 1 |a García, C.C. 
773 0 |d 2009  |g v. 84  |h pp. 31-37  |k n. 1  |p Antiviral Res.  |x 01663542  |w (AR-BaUEN)CENRE-3746  |t Antiviral Research 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249213996&doi=10.1016%2fj.antiviral.2009.07.001&partnerID=40&md5=8f36609ad6d1f1d0be9e4c508b8c92df  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.antiviral.2009.07.001  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_01663542_v84_n1_p31_Artuso  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01663542_v84_n1_p31_Artuso  |y Registro en la Biblioteca Digital 
961 |a paper_01663542_v84_n1_p31_Artuso  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 84029